Shy ME - Search Results

1

Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.

Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR. Garbern JY, et al. Among authors: shy me. Brain. 2002 Mar;125(Pt 3):551-61. doi: 10.1093/brain/awf043. Brain. 2002. PMID: 11872612

2

Mitogen-expanded Schwann cells retain the capacity to myelinate regenerating axons after transplantation into rat sciatic nerve.

Feltri ML, Scherer SS, Wrabetz L, Kamholz J, Shy ME. Feltri ML, et al. Among authors: shy me. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8827-31. doi: 10.1073/pnas.89.18.8827. Proc Natl Acad Sci U S A. 1992. PMID: 1326765 Free PMC article.

3

An adenoviral vector can transfer lacZ expression into Schwann cells in culture and in sciatic nerve.

Shy ME, Tani M, Shi YJ, Whyatt SA, Chbihi T, Scherer SS, Kamholz J. Shy ME, et al. Ann Neurol. 1995 Sep;38(3):429-36. doi: 10.1002/ana.410380313. Ann Neurol. 1995. PMID: 7668829

4

Axon-Schwann cell interactions regulate the expression of c-jun in Schwann cells.

Shy ME, Shi Y, Wrabetz L, Kamholz J, Scherer SS. Shy ME, et al. J Neurosci Res. 1996 Mar 1;43(5):511-25. doi: 10.1002/(SICI)1097-4547(19960301)43:5<511::AID-JNR1>3.0.CO;2-L. J Neurosci Res. 1996. PMID: 8833086

5

Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP).

Shy ME, Arroyo E, Sladky J, Menichella D, Jiang H, Xu W, Kamholz J, Scherer SS. Shy ME, et al. J Neuropathol Exp Neurol. 1997 Jul;56(7):811-21. J Neuropathol Exp Neurol. 1997. PMID: 9210878

6

Modulation of cell-mediated immunity prolongs adenovirus-mediated transgene expression in sciatic nerve.

Jani A, Menichella D, Jiang H, Chbihi T, Acsadi G, Shy ME, Kamholz J. Jani A, et al. Among authors: shy me. Hum Gene Ther. 1999 Mar 20;10(5):787-800. doi: 10.1089/10430349950018544. Hum Gene Ther. 1999. PMID: 10210146

7

Introduction to the Third International Symposium on Charcot-Marie-Tooth disorders.

Shy ME, Kamholz J, Lovelace RE. Shy ME, et al. Ann N Y Acad Sci. 1999 Sep 14;883:xiii-xviii. Ann N Y Acad Sci. 1999. PMID: 10586222 Review. No abstract available.

8

Overcoming cellular immunity to prolong adenoviral-mediated gene expression in sciatic nerve.

Jani A, Menichella D, Jiang H, Chbihi T, Acsadi G, Kamholz J, Shy ME. Jani A, et al. Among authors: shy me. Ann N Y Acad Sci. 1999 Sep 14;883:397-414. Ann N Y Acad Sci. 1999. PMID: 10586264

9

Correlation between weakness and axonal loss in patients with CMT1A.

Krajewski K, Turansky C, Lewis R, Garbern J, Hinderer S, Kamholz J, Shy ME. Krajewski K, et al. Among authors: shy me. Ann N Y Acad Sci. 1999 Sep 14;883:490-2. Ann N Y Acad Sci. 1999. PMID: 10586281

10

Charcot-Marie-Tooth disease type 1: molecular pathogenesis to gene therapy.

Kamholz J, Menichella D, Jani A, Garbern J, Lewis RA, Krajewski KM, Lilien J, Scherer SS, Shy ME. Kamholz J, et al. Among authors: shy me. Brain. 2000 Feb;123 ( Pt 2):222-33. doi: 10.1093/brain/123.2.222. Brain. 2000. PMID: 10648431 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters